Citadel Advisors »

Exagen shares owned by Citadel Advisors

Quarter-by-quarter ownership of Exagen (XGN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Exagen

Tip: Access up to 7 years of quarterly data

All positions including Exagen held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exagen by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $42k 21k 1.99
2023-03-31 $29k 12k 2.43
2022-06-30 $913k 160k 5.72
2022-03-31 $874k 109k 8.03

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Exagen

Cowen And Company
Daniel D. Thurber
Perkins Capital Management
Vanguard Group
Nantahala Capital Management
Penbrook Managment
UBS Group
Dimensional Fund Advisors
Millennium Management
Citadel Advisors
Palumbo Wealth Management
First Bank & Trust
Hanson McClain Advisors
Bank of America Corporation
Barclays

View all funds holding Exagen